Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy
Background. So-called rational drug design is suboptimal when it comes to finding effective and safe drug-based treatment for COVID-19. Another approach seems promising: to reprofile the pharmaceuticals registered in the Anatomical, Therapeutic, and Chemical Classifier (ATC).Material and methods. Ch...
Saved in:
| Main Authors: | I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, Yu. I. Zhuravlev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2021-07-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/527 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differential chemoreactome analysis of glucosamine sulfate and non-steroidal anti-inflammatory drugs: promising synergistic drug combinations
by: O. A. Gromova, et al.
Published: (2018-06-01) -
Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis?
by: A. M. Lila, et al.
Published: (2020-08-01) -
On the anticoagulant and antiaggregatory properties of a glucosamine sulfate molecule
by: I. Yu. Torshin, et al.
Published: (2019-09-01) -
The genetic diversity and populational specificity of the human gut virome at single-nucleotide resolution
by: Xiuchao Wang, et al.
Published: (2025-08-01) -
Gut virome profile in new onset treatment naïve Saudi children with ulcerative colitis
by: Mohammad El Mouzan, et al.
Published: (2025-07-01)